Physician profile
Michael S Lofgren
NPI 1104099241
$9,051.75
in general payments reported to CMS, 2019-2025
14 companies · $585 in 2025
The $585 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,623 · 2020: $3,002 · 2021: $1,474 · 2022: $512 · 2023: $548 · 2024: $309 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349 · Entertainment: $92.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.26 |
| Entertainment | $92.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $4,811.14 | 2019-2025 | |
| Mentor Worldwide LLC | $1,718.11 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Stryker Corporation | $796.62 | 2021-2022 | |
| Merz North America, INC. | $695.23 | 2019 | |
| Allergan, INC. | $404.02 | 2019-2022 | |
| Becton, Dickinson and Company | $166.66 | 2019 | |
| Abbvie INC. | $165.99 | 2023-2025 | |
| Avita Medical Americas, LLC | $56.99 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Medtronic, INC. | $50.00 | 2021 | |
| Sientra, INC. | $44.99 | 2021-2022 | |
| Ethicon US, LLC | $44.80 | 2025 | Surgicel Nu-Knit, Stratafix |
| Integra Lifesciences Corporation | $41.81 | 2021-2023 | Durasorb Monofilament Mesh |
| Davol INC. | $27.77 | 2022 | |
| Galderma Laboratories, L.P. | $27.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lofgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.